This international course offers 3,5 days of lectures and discussions centered on the biology of immunity and cancer immunotherapy. Conferences are delivered by experts who will present the latest developments in the different fields of immunology, including innate immunity, myeloid and lymphoid cell biology, and the microenvironment’s role in the activation of immunity.

A thematic session will cover the state-of-the-art in cell therapy for cancer. A round table on industrial opportunities associated to immunotherapies and career development in the field of immuno-oncology will be organized. Participants will have the opportunity to present their research during two poster sessions and may be selected for a short oral presentation. In addition to highlighting the latest basic and applied research results in immunology, this workshop aims at fostering discussions and collaborations between participants.

Course in English. Registration deadline March 15th, 2023.

Arthur, Sandra and Sarah Irving together with the Mass General Cancer Center are excited to announce the second annual “Arthur and Sandra Irving Cancer Immunology Symposium” to be held on June 26–29, 2023. The Symposium will bring together about 15 accomplished faculty mentors who are excited to share their discoveries and research career experience in cancer immunology with approximately 45 promising young scientists (post-docs and starting PIs).
Applicants are selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. Deadline to apply: Tuesday, January 31, 2023

Registration is now open for the annual FITC day. For their fourth edition, FITC invites you to meet on Tuesday 12 September 2023 at the Institut Curie, in Paris.​ Registration is free for medical and research staff.​ Access the program here.

OBJECTIVES

•Gather the immuno-oncology research stakeholders at national and international level
•Promote the young generation of scientists
•Discuss key issues and perspectives around the development of current and future immunotherapies

SCIENTIFIC PLANNING COMMITTEE

Mustafa Diken, Johannes Gutenberg University, Mainz, Germany
Marina Garassino, University of Chicago, Chicago, Illinois, USA
Nir Hacohen, Broad Institute of MIT and Harvard; Massachusetts General Hospital, Boston, Massachusetts, USA
Susan M. Kaech, The Salk Institute for Biological Studies, La Jolla, California, USA
Paola Nisticò, Regina Elena National Cancer Institute, Rome, Italy
Pamela S. Ohashi, University of Toronto, Toronto, ON, Canada
Catherine Sautès-Fridman, University Paris-Descartes, Paris, France
Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Özlem Türeci, BioNTech SE, Mainz, Germany
Cassian Yee, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Laurence Zitvogel, Gustave Roussy Institute, Villejuif, France

MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalized medicine. The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology await you for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance. The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

CONFERENCE COCHAIRS:

Philip D. Greenberg, Fred Hutchinson Cancer Research Center, Seattle, Washington
Pamela S. Ohashi, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York
Mario Sznol, Yale University, New Haven, Connecticut

ESMO 2023 will disseminate the latest cutting-edge data, provide high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

TBD

The Leipzig Immune ONcology (LION) Conference will focus on the latest developments in immune oncology and provide a forum for leading scientists, clinicians, and industry professionals to exchange ideas and discuss new findings in this exciting field. You are invited to submit your abstracts for oral and poster presentations at the conference. In addition to a stimulating scientific program, the conference will feature networking opportunities, including a welcome reception and poster sessions, as well as an industry exhibition showcasing the latest technologies and services related to cancer immunotherapy research. The LION Conference is organized by the Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Hospital Leipzig.

ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.